Page last updated: 2024-11-05

tripelennamine and ENT Diseases

tripelennamine has been researched along with ENT Diseases in 1 studies

Tripelennamine: A histamine H1 antagonist with low sedative action but frequent gastrointestinal irritation. It is used to treat ASTHMA; HAY FEVER; URTICARIA; and RHINITIS; and also in veterinary applications. Tripelennamine is administered by various routes, including topically.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
ZWERLING, MH1

Other Studies

1 other study available for tripelennamine and ENT Diseases

ArticleYear
Tripelennamine as a topical anesthetic in otolaryngology.
    Eye, ear, nose & throat monthly, 1959, Volume: 38, Issue:1

    Topics: Analgesia; Anesthesia; Anesthesia and Analgesia; Anesthesia, Local; Anesthetics, Local; Otolaryngolo

1959